68528-80-3

Usage

Uses

Used in Immunoprecipitation:
DISUCCINIMIDYL SUBERATE is used as a supplement in Pierce lysis buffer for immunoprecipitation, aiding in the isolation of specific proteins from a complex mixture.
Used in Oligonucleotide Conjugation:
DISUCCINIMIDYL SUBERATE is used as a conjugation agent for attaching oligonucleotide standards to gelatin, enhancing the stability and functionality of the oligonucleotides.
Used in Cross-linking of ASC Oligomers:
DISUCCINIMIDYL SUBERATE is used as a cross-linking agent for the formation of apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) oligomers, playing a crucial role in the regulation of inflammatory responses.
Used in Protein Cross-linking:
DISUCCINIMIDYL SUBERATE is used as a bifunctional cross-linking reagent in the cross-linking of proteins in intact cells, providing insights into protein-protein interactions and cellular processes.
Used in Drug Delivery Systems:
DISUCCINIMIDYL SUBERATE is used as a crosslinker in the development of drug delivery systems, particularly for enhancing the delivery, bioavailability, and therapeutic outcomes of certain molecules.

InChI:InChI=1/C16H20N2O8/c19-11-7-8-12(20)17(11)25-15(23)5-3-1-2-4-6-16(24)26-18-13(21)9-10-14(18)22/h1-10H2

Upstream product

• 6066-82-6 1-hydroxy-pyrrolidine-2,5-dione 
• 505-48-6 octane-1,8-dioic acid 

Downstream Products

• 675587-74-3 2-(benzyloxycarbonylamino)-6-(7-carboxyheptanoylamino)hexanoic acid 
• 675587-73-2 2-(benzyloxycarbonylamino)-6-(7-(5-(benzyloxycarbonylamino)-5-carboxypentylaminocarbonyl)heptanoylamino)hexanoic acid 
• 1045709-75-8 2-{3-[5-[7-(2,5-dioxopyrrolidin-1-yloxycarbonyl)heptanoylamino]-1-(4-methoxybenzyloxycarbonyl)pentyl]ureido}pentanedioic acid bis-(4-methoxybenzyl) ester 
• 1206821-69-3 C₈₄H₁₂₇N₁₇O₂₈S 
• 1446417-16-8 (R)-2-(8-(((R)-1-carboxy-2-(tritylthio)ethyl)amino)-8-oxooctanamido)-3-(tritylthio)propanoic acid 
• 1504585-21-0 C₅₅H₆₁N₇O₁₇ 

Relevant academic research and scientific papers

Double strand DNA cleavage with a binuclear iron complex

Covalently linking two single strand DNA cleaving agents resulted in a new biomimetic binuclear iron complex capable of effecting oxidative double strand DNA cleavage. The Royal Society of Chemistry.

DLL3-TARGETING MULTISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF

The disclosure provides multispecific antigen-binding molecules that comprise a first antigen-binding moiety and a second antigen-binding moiety, each of which is capable of binding to CD3 and CD137, but does not bind to CD3 and CD137 at the same time; and a third antigen-binding moiety that is capable of binding to DLL3, preferably human DLL3, which induce T-cell dependent cytotoxity more efficiently whilst circumventing adverse toxicity concerns or side effects that other multispecific antigen-binding molecules may have. The present invention provides multispecific antigen-binding molecules and pharmaceutical compositions that can treat various cancers, especially those associated with DLL3, by comprising the antigen-binding molecule as an active ingredient.

NON-HUMAN ANIMAL HAVING HUMAN CD3 GENE SUBSTITUTED FOR ENDOGENOUS CD3 GENE

The present invention provides genetically modified non-human animals which are deficient in at least one or more types of CD3 genes selected from the group consisting of endogenous CD3ε, CD3δ, and CD3γ in its genome and functionally express at least one or more types of human CD3 genes selected from the group consisting of human CD3?, CD3δ, and CD3γ. In the genetically modified non-human animals of the present invention, mature T cell differentiation and production can take place, and immunocompetent cells including T cells can exert their functions. The genetically modified non-human animals of the present invention enable efficient evaluation and screening in the development of therapeutic agents and therapeutic methods that use human CD3-mediated targeted drugs.

SITE SELECTIVE CONJUGATION OF AN OLIGONUCLEOTIDE CONJUGATE OR A SMALL MOLECULE TO A METAL BINDING PROTEIN

The present invention relates to methods for site selective conjugation of an oligonucleotide conjugate to a metal binding protein comprising a metal binding site and for site selective conjugation of a small molecule conjugation compound (SMCoC) to an antibody comprising a metal binding site, metal binding protein conjugates obtainable by said methods, and uses of said metal binding protein conjugates.

Preparation and properties of gelatin films incorporated with N-hydroxysuccinimide-activated end-bit binary acid

A series of novel cross-linkers, N-hydroxysuccinimide (NHS)-activated end-bit binary acid (NHS-C4, C5, C6, C8, C10, C14), were synthesised to modify gelatin films and the crosslinking effects were compared. Homogeneous films with the exception of the film crosslinked by NHS-C14 were observed and the thickness was measured using a scanning electron microscope. The section feature influenced by different film-treatment conditions was also recorded. The differential scanning calorimetry results indicated higher thermal stability. The water contact angles confirmed enhanced hydrophobicity. NHS-C6, which was used as a probe crosslinker, exhibited the best crosslinking effect that the content of the free -NH2 achieved was the lowest out of all the crosslinkers. The biodegradation results of gelatin films modified by NHS-C6 exhibited better degradation-resistance and excellent stability. In addition, the optimal experimental conditions were 45°C for 12 h when [NHS-C6]/[-NH2] = 2.5.

Dynamic combinatorial chemistry with novel dithiol building blocks: Towards new structurally diverse and adaptive screening collections

We describe the synthesis of a range of novel dithiol-functionalized building blocks and demonstrate how they can be used to generate new structurally diverse dynamic combinatorial libraries. A proof-of-principle experiment using the catecholamine dopamine revealed that molecular recognition changed the library composition under biocompatible conditions and identified new promising candidate receptors of this biologically important neurotransmitter. Georg Thieme Verlag Stuttgart - New York.